Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
long-term effects on NAD+ metabolism, liver function, and cardiovascular health are unknown
What does the clinical evidence actually show
The compound showed no hepatotoxicity or nephrotoxicity in healthy participants, but individuals with compromised liver or kidney function metabolise and clear compounds differently
Mechanism-focused studies may include receptor-pathway assays, biomarker panels, gene-expression analysis, protein-expression studies, cell-viability controls, migration assays, metabolic marker analysis, or stability testing
Monitor blood pressure weekly as weight loss may require blood pressure medication adjustment
Reduction of Abdominal and Visceral Fat : Animal and early human models have demonstrated a preferential reduction of abdominal fat following subcutaneous administration of AOD-9604
&srotate=0)
